Genetic Analysis of African American Hypertensive End-Stage Renal Disease
非裔美国人高血压终末期肾病的基因分析
基本信息
- 批准号:7417955
- 负责人:
- 金额:$ 38.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-05-01 至 2010-04-30
- 项目状态:已结题
- 来源:
- 关键词:6p239p21.3AccountingAffectAfrican AmericanAllelesAmericanCandidate Disease GeneCaringChromosome MappingCollectionDNA SequenceDataData AnalysesDatabasesDevelopmentDiabetes MellitusDialysis patientsDiseaseEnd stage renal failureEuropeanFamilyGenesGenetic PolymorphismGenetic Predisposition to DiseaseGenome ScanGenomicsGenotypeHaplotypesHigh Blood PressureHypertensionHypotensionIncidenceIndividualKidney DiseasesKidney FailureLeadLinkage DisequilibriumMapsMedicalMethodsMicrosatellite RepeatsMinorityMolecular GeneticsPathway interactionsPatientsPharmaceutical PreparationsPhasePolymorphism AnalysisPopulationPredispositionProcessPublishingRateRecruitment ActivityRelative (related person)Renal HypertensionResearch PersonnelResourcesRiskSamplingSiblingsSignal TransductionSingle Nucleotide PolymorphismSingle Nucleotide Polymorphism MapSocioeconomic StatusStagingStructureSurveysSusceptibility GeneTestingUnited StatesUnited States Centers for Medicare and Medicaid Servicesbasecase controldensitydesigngenetic analysisgenetic linkage analysisgenetic pedigreeindexingmembernovelpositional cloningprevent
项目摘要
DESCRIPTION (provided by investigator): The focus of this application is to locate and identify one or more genes that cause hypertension-associated end-stage renal (H-ESRD) disease in the African American population. Hypertensive end-stage renal disease is one of the leading causes of kidney failure in the United States and it disproportionately affects African Americans. This application builds upon a genome scan in 264 African American families containing index cases with H-ESRD and their siblings with end-stage kidney failure. We will perform fine mapping of the regions with the strongest evidence of linkage in the genome scan analysis. Linkage support intervals defined by the fine mapping process will be prioritized based on the evidence for linkage in our sample and other published data. High priority regions will be surveyed for candidate genes that could contribute to hypertension and H-ESRD. These genes will be subjected to a focused high density single nucleotide polymorphism (SNP) mapping effort, block identification and tested for association (e.g., single locus and haplotype) under a case-control design. The case-control sample is independent of the genome scan sample. The signal locus and haplotype analyses should help identify individual polymorphisms and haplotypes that are in linkage disequilibrium with H-ESRD. We anticipate that an intensive genetic analysis for the identification of haplotype blocks will facilitate the search for polymorphisms. Mapping the genes that predispose to hypertensive kidney disease will provide a framework for identifying the pathways that initiate or promote renal failure and could ultimately lead to the development of novel medications to prevent or slow progression of hypertensive kidney failure in African Americans.
描述(由研究人员提供):这项应用的重点是定位和识别在非裔美国人群体中导致高血压相关终末期肾脏(H-ESRD)疾病的一个或多个基因。高血压终末期肾病是美国肾衰竭的主要原因之一,它对非裔美国人的影响不成比例。这一应用程序建立在264个非裔美国家庭的基因组扫描基础上,这些家庭包含H-ESRD及其兄弟姐妹患有终末期肾功能衰竭的索引病例。我们将在基因组扫描分析中对具有最强连锁证据的区域进行精细绘制。将根据我们样本中的链接证据和其他公布的数据来确定精细绘图过程中定义的链接支持间隔的优先顺序。将对高优先级区域进行调查,以寻找可能导致高血压和H-ESRD的候选基因。这些基因将在病例对照设计下进行集中的高密度单核苷酸多态(SNP)定位、区块鉴定和关联测试(例如,单基因座和单倍型)。病例对照样本独立于基因组扫描样本。信号位点和单倍型分析有助于识别与H-ESRD连锁不平衡的个体多态和单倍型。我们预计,对单倍型区块进行密集的遗传分析将有助于寻找多态。绘制高血压肾病易感基因的图谱将为识别引发或促进肾功能衰竭的途径提供一个框架,并最终可能导致开发新的药物来预防或减缓非裔美国人高血压肾功能衰竭的进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BARRY Ira FREEDMAN其他文献
BARRY Ira FREEDMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BARRY Ira FREEDMAN', 18)}}的其他基金
SUBCLINICAL CVD IN AFRICAN AMERICAN TYPE 2 DIABETICS
非裔美国人 2 型糖尿病患者的亚临床 CVD
- 批准号:
8167007 - 财政年份:2010
- 资助金额:
$ 38.15万 - 项目类别:
GENETICS OF AFRICAN AMERICAN TYPE 2 DIABETES HIGH BLOOD PRESSURE
非裔美国人 2 型糖尿病高血压的遗传学
- 批准号:
7951374 - 财政年份:2009
- 资助金额:
$ 38.15万 - 项目类别:
SUBCLINICAL CVD IN AFRICAN AMERICAN TYPE 2 DIABETICS
非裔美国人 2 型糖尿病患者的亚临床 CVD
- 批准号:
7951373 - 财政年份:2009
- 资助金额:
$ 38.15万 - 项目类别:
Subclinical CVD in African American Type 2 Diabetics
非裔美国人 2 型糖尿病患者的亚临床 CVD
- 批准号:
8690833 - 财政年份:2007
- 资助金额:
$ 38.15万 - 项目类别:
Subclinical CVD in African American Type 2 Diabetics
非裔美国人 2 型糖尿病患者的亚临床 CVD
- 批准号:
7636852 - 财政年份:2007
- 资助金额:
$ 38.15万 - 项目类别:
Subclinical CVD in African American Type 2 Diabetics
非裔美国人 2 型糖尿病患者的亚临床 CVD
- 批准号:
7319002 - 财政年份:2007
- 资助金额:
$ 38.15万 - 项目类别:
相似国自然基金
染色体9p21.3区域遗传变异与体细胞突变在食管鳞癌发生中的作用及其生物学机制研究
- 批准号:81572421
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
5p15.33、7p11.2、8q24.21、9p21.3、11q23.3和20q13.33座位遗传多态与胶质母细胞瘤放疗后生存的关系研究
- 批准号:81372417
- 批准年份:2013
- 资助金额:16.0 万元
- 项目类别:面上项目
相似海外基金
Targeting protein arginine methylation in the 9p21.3 loss tumor microenvironment
9p21.3 缺失肿瘤微环境中的靶向蛋白精氨酸甲基化
- 批准号:
489995 - 财政年份:2023
- 资助金额:
$ 38.15万 - 项目类别:
Operating Grants
Targeting protein arginine methylation in the 9p21.3 loss tumor microenvironment
9p21.3 缺失肿瘤微环境中的靶向蛋白精氨酸甲基化
- 批准号:
498862 - 财政年份:2023
- 资助金额:
$ 38.15万 - 项目类别:
Operating Grants
Tumor and immune determinants of effective anti-tumor immunity in renal cell carcinoma
肾细胞癌有效抗肿瘤免疫的肿瘤和免疫决定因素
- 批准号:
10638907 - 财政年份:2023
- 资助金额:
$ 38.15万 - 项目类别:
Comprehensive functional genomic analysis of the multi-disease associated CDKN2A/B locus
多种疾病相关 CDKN2A/B 基因座的综合功能基因组分析
- 批准号:
10672975 - 财政年份:2021
- 资助金额:
$ 38.15万 - 项目类别:
Functional Characterization of Glioma GWAS Variants
胶质瘤 GWAS 变异体的功能表征
- 批准号:
9159686 - 财政年份:2016
- 资助金额:
$ 38.15万 - 项目类别:
Identification and study of the vascular disease gene at 9p21.3
9p21.3血管疾病基因的鉴定与研究
- 批准号:
8467030 - 财政年份:2010
- 资助金额:
$ 38.15万 - 项目类别:
Identification and study of the vascular disease gene at 9p21.3
9p21.3血管疾病基因的鉴定与研究
- 批准号:
8280216 - 财政年份:2010
- 资助金额:
$ 38.15万 - 项目类别:
Identification and study of the vascular disease gene at 9p21.3
9p21.3血管疾病基因的鉴定与研究
- 批准号:
7937672 - 财政年份:2010
- 资助金额:
$ 38.15万 - 项目类别:
Identification and study of the vascular disease gene at 9p21.3
9p21.3血管疾病基因的鉴定与研究
- 批准号:
8110010 - 财政年份:2010
- 资助金额:
$ 38.15万 - 项目类别:
Establishment of a bioresource for discovery and evaluation of genetic and other
建立用于发现和评估遗传及其他生物资源的生物资源
- 批准号:
7893707 - 财政年份:2009
- 资助金额:
$ 38.15万 - 项目类别:














{{item.name}}会员




